While the pan-AKT inhibitor capivasertib was not cytotoxic by itself, the addition of capivasertib to trametinib significantly enhanced the apoptotic activity induced by trametinib alone in BAKP (Figure 2A) and POT (Figure 2B) melanoma cell lines. This evidence concerns the gene AKT1 and melanoma.